Search Results - "Hogerman, Deborah A"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM197 in United States Infants by Rennels, Margaret B, Edwards, Kathryn M, Keyserling, Harry L, Reisinger, Keith S, Hogerman, Deborah A, Madore, Dace V, Chang, Ih, Paradiso, Peter R, Malinoski, Frank J, Kimura, Alan

    Published in Pediatrics (Evanston) (01-04-1998)
    “…To determine the safety and immunogenicity of heptavalent pneumococcal saccharide vaccine (serotypes 4, 6B, 9V, 14, 18C, 19F, 23F) individually conjugated to…”
    Get full text
    Journal Article
  2. 2

    Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis by PIEDRA, PEDRO A, GRACE, SUSAN, JEWELL, ALAN, SPINELLI, SUSAN, HOGERMAN, DEBORAH A, MALINOSKI, FRANK, HIATT, PETER W

    Published in The Pediatric infectious disease journal (01-03-1998)
    “…BACKGROUND.We recently showed the clinical benefit of the PFP-2 vaccine for respiratory syncytial virus (RSV) for children with cystic fibrosis (CF)…”
    Get full text
    Journal Article
  3. 3

    Safety and immunogenicity of a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants by PARADISO, P. R, HOGERMAN, D. A, MADORE, D. V, KEYSERLING, H, KING, J, REISINGER, K. S, BLATTER, M. M, ROTHSTEIN, E, BERNSTEIN, H. H, HACKELL, J

    Published in Pediatrics (Evanston) (01-12-1993)
    “…To study the safety and immunogenicity of a combined diphtheria-tetanus-pertussis (DTP)-Haemophilus influenzae type b (HbOC) vaccine (TETRAMUNE) in infants as…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis by PIEDRA, P. A, GRACE, S, JEWELL, A, SPINELLI, S, BUNTING, D, HOGERMAN, D. A, MALINOSKI, F, HIATT, P. W

    “…To test in a double blind, placebo-controlled study a purified fusion protein (PFP-2) vaccine against respiratory syncytial virus (RSV) in RSV-seropositive…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody persistence and possible disease enhancement by Tristram, D A, Welliver, R C, Hogerman, D A, Hildreth, S W, Paradiso, P

    Published in Vaccine (01-05-1994)
    “…In a previous study, children 18 to 36 months of age and seropositive for respiratory syncytial virus (RSV) were vaccinated with an RSV subunit vaccine (PFP-1)…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Safety and immunogenicity of a combined diptheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants by Paradiso, Peter R, Hogerman, Deborah A, Madore, Dace Viceps, Keyserling, Harry

    Published in Pediatrics (Evanston) (01-12-1993)
    “…A study to examine the safety and immunogenicity of a combined diptheria-tetanus-pertussis-Haemophilus influenzae type b vaccine in infants as young as two…”
    Get full text
    Journal Article
  10. 10